Find Grants

Search results

• Active

  MARS: Morquio A Registry

  Burton, B. K. & Charrow, J.

  BioMarin Pharmaceutical Inc.

  12/15/14 → 8/31/50

  Project: Research project

• A Phase II, Randomized, Double-blind, Placebo-controlled study to examine the effects of DAS181 in immunocompromised subjects with Lower Respiratory Tract Parainfluenza Infection on Supplemental Oxygen

  Chaudhury, S.

  Ansun Biopharma, Inc.

  12/1/14 → 8/31/50

  Project: Research project

• Protocol #A5002: INTREPID: Implantable Neurostimulator for the Treatment of Parkinson's disease

  Rosenow, J. M.

  Boston Scientific Neuromodulation Corporation

  11/19/14 → 11/19/23

  Project: Research project

• Prot #CPR-03434: A Prospective, Randomized, Controlled Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Single-Lobe Treatment of Severe Emphysema

  Kalhan, R.

  Spiration, Inc.

  11/4/14 → 11/4/23

  Project: Research project

• RECENSUS: A Medical Chart Review of Patients with X-Linked Myotubular Myopathy (XLMTM)

  Kuntz, N. L.

  Audentes Therapeutics, Inc.

  11/1/14 → 8/31/50

  Project: Research project

• Prot #HGS1006-C1124: A 5-Year Prospective Observational Registry to Assess Adverse Events of Interest and Effectiveness in Adults with Active, Autoantibody-Positive Systemic Lupus Erythematosus Treated with or without BENLYSTA™ (belimumab)

  Hsieh, C.

  Outcome Sciences Inc., GlaxoSmithKline LLC

  10/9/14 → 10/10/22

  Project: Research project

• Prot #P11-282: A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Patients with Moderately to Severely Active Ulcerative Colitis (UC)

  Hanauer, S. B.

  Mapi USA, Inc., AbbVie Inc.

  10/2/14 → 10/2/24

  Project: Research project

• SWOG Clinical Trials Initiative Purchased Service Agreement

  Hussain, M.

  SWOG - Clinical Trials Initiative LLC

  10/1/14 → 9/30/24

  Project: Research project

• Randomized Conversion of EBV+ Kidney Transplant Recipients of Living or Standard Criteria Donors at Three Months Post Transplantation to Belatacept with MPA or Belatacept with Low-Dose Tacrolimus (50% of Dose) Compared to Patients Remaining on Center Spec

  Gallon, L. & Leventhal, J. R.

  Bristol-Myers Squibb Company

  9/9/14 → 9/9/22

  Project: Research project

• A Phase 3, Randomized, Double-blind, Sham-Procedure Controlled Study to Assess the Clinical Efficacy and Safety of ISIS 396443 Administered Intrathecally in Patients with Infantile-onset Spinal Muscular Atrophy

  Kuntz, N. L.

  Ionis Pharmaceuticals, Inc.

  9/1/14 → 8/31/50

  Project: Research project

• Joint Appointment Agreement - Petriello

  Randolph, A. & Petriello, F. J.

  UChicago Argonne, LLC, Argonne National Laboratory, Department of Energy

  9/1/14 → 8/31/22

  Project: Research project

• Evaluating Northwestern Medicine Community Outreach - Additional

  Ackermann, R. T.

  Northwestern Memorial Hospital

  9/1/14 → 8/31/22

  Project: Research project

• Molecular Targeting of Dietary Therapy for Eosinophilic Esophagitis

  Wershil, B. K.

  Campaign Urging Research for Eosinophilic Disease (CURED)

  9/1/14 → 8/31/50

  Project: Research project

• A Phase 3, Randomized, Double-blind, Sham-Procedure Controlled Study to Assess the Clinical Efficacy and Safety of ISIS 396443 Administered Intrathecally in Patients with Infantile-onset Spinal Muscular Atrophy

  Kuntz, N. L.

  Ionis Pharmaceuticals, Inc.

  9/1/14 → 8/31/50

  Project: Research project

• A Phase 3, Randomized, Double-blind, Sham-Procedure Controlled Study to Assess the Clinical Efficacy and Safety of ISIS 396443 Administered Intrathecally in Patients with Infantile-onset Spinal Muscular Atrophy

  Kuntz, N. L.

  Ionis Pharmaceuticals, Inc.

  9/1/14 → 8/31/50

  Project: Research project

• Argonne Joint Appointment - Poeppelmeier

  Randolph, A., Ratner, M. A. & Poeppelmeier, K.

  UChicago Argonne, LLC, Argonne National Laboratory, Department of Energy

  9/1/14 → 8/31/22

  Project: Research project

• Argonne Joint Appointment - Kanatzidis

  Randolph, A., Ratner, M. A. & Kanatzidis, M.

  UChicago Argonne, LLC, Argonne National Laboratory, Department of Energy

  9/1/14 → 8/31/22

  Project: Research project

• Argonne Joint Appointment - Low

  Randolph, A., Ratner, M. A. & Low, I.

  UChicago Argonne, LLC, Argonne National Laboratory, Department of Energy

  9/1/14 → 8/31/22

  Project: Research project

• Prot #SARC024: A blanket protocol to study oral regorafenib in patients with selected sarcoma subtypes

  Agulnik, M.

  SARC

  8/27/14 → 12/16/22

  Project: Research project

• Prot # CT-10-05: INTERPRET Cardiac Inotrope Patient Registry Program

  Rich, J. D.

  Coram Clinical Trials, Inc.

  8/25/14 → 8/24/23

  Project: Research project

• REPRIEVE A5332 and A5333s

  Taiwo, B. O.

  Massachusetts General Hospital, National Heart, Lung, and Blood Institute

  8/8/14 → 4/30/23

  Project: Research project

• Northwestern Cystic Fibrosis Success with Therapies Research Consortium

  Prickett, M.

  Cystic Fibrosis Foundation Therapeutics, Inc.

  8/1/14 → 7/31/23

  Project: Research project

• LUM001 - ITCH (301) and IMAGINE (305) protocols, sponsor agreement in addition to funds supplied by the NIH ChiLDReN Grant (U01 DK-062456) and University of Michigan Subcontract (Lurie proposal 15-0334)

  Whitington, P. F.

  Lumena Pharmaceuticals, LLC

  8/1/14 → 8/30/50

  Project: Research project

• Arryman Program: Ririn Radiawati Kusuma

  Cherry, H. L. & Hurst, W.

  Indonesian Scholarship and Research Support Foundation

  7/1/14 → 6/30/25

  Project: Research project

• Arryman Program: Bambang Trihadmojo

  Cherry, H. L. & Hurst, W.

  Indonesian Scholarship and Research Support Foundation

  7/1/14 → 6/30/25

  Project: Research project